Statins and Inflammation in Cardiovascular Disease

Area of Science:

• Cardiovascular Medicine
• Immunology
• Pharmacology

Background:

• Chronic inflammation and immune activation are central to various cardiovascular diseases, including atherosclerosis, hypertension, and heart failure.
• Statins, primarily known for lowering cholesterol by inhibiting hepatic cholesterol biosynthesis, also exhibit significant anti-inflammatory effects.
• These anti-inflammatory actions stem from inhibiting GTPase isoprenylation, impacting secondary pathways and immune cell function.

Purpose of the Study:

• To review the anti-inflammatory mechanisms of statins in cardiovascular disease.
• To correlate experimental findings with clinical data on statin efficacy.

Main Methods:

• Systematic literature search of PubMed and Cochrane Database.
• Inclusion of trials, studies, guidelines, and novel articles on statins and cardiovascular inflammation.

Main Results:

• In vitro studies demonstrate statins' immunomodulatory and anti-inflammatory effects, independent of lipid-lowering.
• Experimental research highlights the role of HMG-CoA reductase inhibitors in heart failure (HF).
• Clinical data suggest statins benefit both systolic and diastolic heart failure.

Conclusions:

• The review consolidates pathophysiological evidence for statins' anti-inflammatory actions.
• Mechanisms are linked to clinical data, confirming potent non-lipid-lowering effects of HMG-CoA reductase inhibitors in cardiovascular disease.